Fin Trust Capital Advisors, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 15 shares of ALNY stock, worth $4,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$4,250
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
671Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.7 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.61 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.71 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.97 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.24 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...